
Asset manager
Avoro Capital Advisors
Avoro Capital is a New York-based life sciences investment manager that backs emerging biotechnology companies across public and private markets, with a private venture arm called Avoro Ventures.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Avoro Capital Advisors right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds Avoro Capital Advisors joined, from press and the firm’s own posts.
Every round Avoro Capital Advisors joined
Round sizes, Avoro Capital Advisors’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Avoro Capital Advisors backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Avoro Capital Advisors
Events where Avoro Capital Advisors’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Avoro Capital Advisors is based in New York, United States.
2 fund vehicles are on public registers (SEC adviser filings), including AVORO LIFE SCIENCES FUND LLC and AVORO VENTURES FUND L.P.
Sectors: Biotech, Life sciences. From the firm’s own website.
Avoro looks for scientific breakthroughs that address unmet medical needs and for unique or mispriced opportunities in biotech. It supports companies financially and intellectually through the investment lifecycle, with active management of core positions and hedging, sizing and liquidity discipline. From the firm’s own website.
Avoro Capital Advisors lists 71 portfolio companies on its website, including Acerta Pharma, Adaptimmune, Adverum Biotechnologoes, Aerie Pharmaceuticals (AERI) and Allogene Therapeutics.
Firms whose websites list some of the same companies include Foresite Capital, Atlas Venture and Frazier Life Sciences.
Know before Avoro Capital Advisors’s next round is announced.
PRO tracks Avoro Capital Advisors’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.